Search
for
Sort by
Research 30 of 1000+
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health
- Assessment of Female Sexual Dysfunction in Patients with Premenopausal Female Pattern Hair Loss
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health
- Which chemicals should be grouped together for mixture risk assessments of male reproductive disorders?
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality
- Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature
- Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review
- Finasteride: suicidality or psychological adverse events
- Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients
- Fertility and Sterility Vol 101 No 4, April 2014
- Editor’s picks January 2021
- The 2018 Revision to the Process of Care Model for Evaluation of Erectile Dysfunction
- Mood disorders and quality of life in polycystic ovary syndrome
- An (Ir)reversible Affection of the Sexual Sphere: A Case Report
- Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health
- One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- The Role of Androgens in Health and Disease in Females: A Narratıve Review
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Advancing Hair Regrowth Assessment: Development and Standardization of Methods for Evaluating New Hair Growth, Hair Keratin Levels, and Scalp Health in Androgenetic Alopecia Patients
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Sexual Dysfunction in Polycystic Ovary Syndrome (PCOS): A Biopsychosocial Approach to Assessment and Management
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Retrospective Assessment of Changes in Perceived Health Status during Continuous Use of a Dietary Supplement